Partneringdesk Deals and Alliances In Autoimmune & Inflammatory DiseasesInnovaro PharmalicensingJune 1, 2006 1048 Pages - SKU: PL1284781 |
|
Calming and Sleeping in Latvia
5/8/2012 | published by: Euromonitor International
In Latvia, there was faster growth for standard calming and sleeping products in 2011. The shift towards more expensive and higher quality products was the major contributor to growth in 2011.The trend of younger consumers
|
more...
|
$900.00
|
|
Calming and Sleeping in Dominican Republic
5/9/2012 | published by: Euromonitor International
Calming and sleeping products are becoming increasingly popular due to the stressful lifestyles of consumers, especially those in large cities. Due to the speed of daily life, having to deal with different environments, work, family
|
more...
|
$900.00
|
|
Freedonia Focus on Diabetes Monitoring Products: United States
5/31/2012 | published by: Freedonia Focus
This report discusses US demand for diabetes monitoring products for the years 2006 and 2011, with forecasts for 2016. Topics covered include market size, product and market segmentation, regulatory considerations, product development, market environment, product
|
more...
|
$600.00
|
|
Calming and Sleeping in Guatemala
5/10/2012 | published by: Euromonitor International
Use of OTC calming and sleeping products is limited in the country. The total market size of this category is GTQ850,800, making it one of the smallest categories in the consumer health market in the
|
more...
|
$900.00
|
|
Calming and Sleeping in Ukraine
5/10/2012 | published by: Euromonitor International
Consumers began to return to calming and sleeping products in 2011. The financial crisis contributed to increased usage of home-made traditional/herbal treatments (eg, valerian root) as a way to economise. However, as the economy showed
|
more...
|
$900.00
|
|
Targeted Health and Wellness Foods and Beverages: The U.S. Market and Global Trends
3/1/2012 | published by: Packaged Facts
The market for targeted health and wellness foods and beverages is a dynamic and promising one, driven largely by the growing recognition—among scientists, government, practitioners, and consumers alike—of the instrumental role diet plays in a
|
more...
|
$3,500.00
|
|
2012 World Cancer Diagnostic Market Overview: Facilities, Test Volumes, and Sales Forecasts by Country
4/17/2012 | published by: Venture Planning Group
This report provides a worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories performing cancer tests, as
|
more...
|
$950.00
|
|
2012 Global HIV/AIDS Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country
4/20/2012 | published by: Venture Planning Group
The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and
|
more...
|
$4,850.00
|
|
2012 Global Tuberculosis Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country
4/20/2012 | published by: Venture Planning Group
The report presents a detailed analysis of the Tuberculosis diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Tuberculosis definition, epidemiology and etiology are reviewed.
|
more...
|
$3,850.00
|
|
Triple Analysis: Angiogenesis, Cancer Vaccines and Protein Kinase Inhibitors
5/1/2012 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies by mechanism/target/effect of Angiogenesis, Cancer Vaccines and Protein Kinase Inhibitors. Each of these three individual parts is evaluated according to standardized criteria in a five pillar
|
more...
|
$5,175.00
|
